Shivinder Jolly

1.1k total citations
4 papers, 109 citations indexed

About

Shivinder Jolly is a scholar working on Nephrology, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Shivinder Jolly has authored 4 papers receiving a total of 109 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Nephrology, 1 paper in Pharmacology and 1 paper in Cardiology and Cardiovascular Medicine. Recurrent topics in Shivinder Jolly's work include Dialysis and Renal Disease Management (1 paper), Pharmacology and Obesity Treatment (1 paper) and Erythropoietin and Anemia Treatment (1 paper). Shivinder Jolly is often cited by papers focused on Dialysis and Renal Disease Management (1 paper), Pharmacology and Obesity Treatment (1 paper) and Erythropoietin and Anemia Treatment (1 paper). Shivinder Jolly collaborates with scholars based in United Kingdom, United States and Spain. Shivinder Jolly's co-authors include T.-Christian H. Mix, Roger S. McLeod, Ángel L.M. de Francisco, H. E. Abboud, Yumi Kubo, Francesco Locatelli, Moetaz Albizem, Geoffrey A. Block, Alexander R. Cobitz and Gregorio T. Obrador and has published in prestigious journals such as The Lancet, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Shivinder Jolly

3 papers receiving 106 citations

Peers

Shivinder Jolly

NEPHR

ND

PFM

SURGE

HEMAT

Janette Mansour France

Agata Winiarska Poland

María Ángeles Cobo Spain

Leena Martola Finland

Holly Mabillard United Kingdom

Bowen Sun China

Evgeny Farber Israel

Roger Wyndham Australia

Gesche Düker Germany

Alan W. McMahon Canada

Janette Mansour France

Shivinder Jolly

85 ×0.9

NEPHR

40 ×1.1

ND

20 ×0.8

PFM

12 ×0.7

SURGE

4 ×0.3

HEMAT

Citations per year, relative to Shivinder Jolly Shivinder Jolly (= 1×) peers Janette Mansour

Countries citing papers authored by Shivinder Jolly

Since Specialization

Citations

This map shows the geographic impact of Shivinder Jolly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shivinder Jolly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shivinder Jolly more than expected).

Fields of papers citing papers by Shivinder Jolly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shivinder Jolly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shivinder Jolly. The network helps show where Shivinder Jolly may publish in the future.

Co-authorship network of co-authors of Shivinder Jolly

This figure shows the co-authorship network connecting the top 25 collaborators of Shivinder Jolly. A scholar is included among the top collaborators of Shivinder Jolly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shivinder Jolly. Shivinder Jolly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Heerspink, Hiddo J.L., José Cardona, Shivinder Jolly, et al.. (2025). Balcinrenone in combination with dapagliflozin compared with dapagliflozin alone in patients with chronic kidney disease and albuminuria: a randomised, active-controlled double-blind, phase 2b clinical trial. The Lancet. 406(10518). 2449–2460.

2.

Johansen, Kirsten L., Alexander R. Cobitz, Ajay Singh, et al.. (2023). The ASCEND-NHQ randomized trial found positive effects of daprodustat on hemoglobin and quality of life in patients with non-dialysis chronic kidney disease. Kidney International. 103(6). 1180–1192. 16 indexed citations

3.

Cobitz, Alexander R., Renato D. Lópes, Ajay Singh, et al.. (2021). Effects of Daprodustat on Hemoglobin and Quality of Life in Patients with CKD: Results of the ASCEND-NHQ Randomized, Double-Blind, Placebo-Controlled Trial. Journal of the American Society of Nephrology. 32(10S). 36–36. 3 indexed citations

4.

Locatelli, Francesco, H. E. Abboud, Ángel L.M. de Francisco, et al.. (2008). A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Cinacalcet HCl in Participants With CKD Not Receiving Dialysis. American Journal of Kidney Diseases. 53(2). 197–207. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact